8-K ·Filed Feb 27, 2026

XERS

Xeris Biopharma Holdings, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001867096-26-000010
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor for the release of the missing exhibit (EX-99.1) which may contain an investor presentation or preliminary financial results. Absent content, no trading decision should be made based on this filing alone.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
XERS ▲ +2.29% at T+60d
NEUTRAL call ✓ call won +2.29% · α vs SPY -7.10% · entry $6.12 → $6.26
Entry anchored
Feb 26, 03:59 PM ET
via exchange tick
T+1d
-1.63%
call -1.63% · α -1.69%
$6.02
settled 7mo ago
T+5d
-5.07%
call -5.07% · α -3.08%
$5.81
settled 7mo ago
T+20d
-11.76%
call -11.76% · α -4.21%
$5.40
settled 6mo ago
T+60d
+2.29%
call +2.29% · α -7.10%
$6.26
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Xeris Biopharma Holdings, Inc. (XERS) includes Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), suggesting a possible investor presentation or public disclosure of material information, but no specific details or financial data are accessible to confirm content or implications.

Key Facts

  • Filing is an 8-K for Xeris Biopharma Holdings, Inc. (XERS)
  • Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
  • No document content available to verify disclosures, financials, or strategic updates
  • Exhibit 99.1 (press release or presentation) was likely filed but not accessible

Financial Impact

Not specified

Risk Factors

  • Material information may have been disclosed that is not reflected in this analysis
  • Potential for market-moving guidance or results being missed due to document unavailability

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

14 reports for XERS
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +24.89%Jun 12, 2026
Filters
Rows
Reports for XERS — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
8-K
BULLISH ★ 6/10
$7.71 $7.78▲ +0.91%▲ +1.56%$9.08 (+17.77%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.58 $7.67▼ −10.61%▼ −9.65%$9.08 (+5.83%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$7.36 $8.33▲ +13.18%▲ +11.97%$9.08 (+23.37%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.19 $8.39▲ +2.44%▲ +2.54%$9.08 (+10.87%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 4/10
$8.94 $8.28▲ +7.38%▲ +7.93%$9.08 (−1.57%)
Jul 2, 2026
13w ago
3
NEUTRAL ★ 3/10
$8.28 $8.62▲ +4.11%▲ +3.18%$9.08 (+9.66%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$8.28 $8.62▲ +4.11%▲ +3.18%$9.08 (+9.66%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$8.00 $8.94▲ +11.75%▲ +11.49%$9.08 (+13.50%)
Jun 12, 2026
16w ago
Institutional Cluster
BULLISH ★ 4/10
$6.79 $6.95▲ +2.36%▲ +1.68%$9.08 (+33.73%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.24 $6.88▲ +10.26%▲ +8.14%$9.08 (+45.51%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (64h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access